SCHEMBL7616767

SCHEMBL7616767

CC(=O)c1cc(S(=O)(=O)NC(=O)Nc2c(C(C)C)cc(Cl)cc2C(C)C)ccc1C.CC(=O)c1cc(S(N)(=O)=O)ccc1C

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 6/20 0.57
CA2 P00918 5/20 0.44
CA1 P00915 4/20 0.44
CA12 O43570 3/20 0.41
CA9 Q16790 3/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
HTT P42858 2/20 0.40
KMT2A Q03164 1/20 0.39
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
FBP1 P09467 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145342 0.95 NLRP3 (0.62) NLRP3CA2CA1HTTKMT2A
SCHEMBL7613834 0.90 NLRP3 (0.57) NLRP3CA2CA1CA12CA9
SCHEMBL7619278 0.87 NLRP3 (0.54) NLRP3CA2CA1CA12CA7
SCHEMBL7135756 0.84 NLRP3 (0.62) NLRP3KMT2AFLT1FLT4KDR
SCHEMBL7142667 0.84 NLRP3 (0.74) NLRP3CA2CA1CA12CA9
SCHEMBL7617403 0.83 NLRP3 (0.66) NLRP3CA2CA1CA12CA9
SCHEMBL7617320 0.82 NLRP3 (0.60) NLRP3CA2CA1CA12CA9
SCHEMBL7145367 0.82 NLRP3 (0.59) NLRP3KMT2AFLT1FLT4KDR
SCHEMBL7140940 0.81 NLRP3 (0.69) NLRP3CA2CA1HTTKMT2A
SCHEMBL7612024 0.81 NLRP3 (0.69) NLRP3CA2CA1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214087-A1 COMBINATION TREATMENT WITH IL-1RA AND COMPOUNDS THAT INHIBIT IL-1 PROCESSING AND RELEASE Pfizer Products Inc. (US) 2002-06-19 EP disclosed
WO-2001019390-A1 COMBINATION TREATMENT WITH IL-1RA AND DIARYL SULPHONYL UREA COMPOUNDS PFIZER PRODUCTS INC. (US) 2001-03-22 WO disclosed